HIGHLIGHTS
- who: Xiang Liu from the University of Alabama at Birmingham, United States have published the article: Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS, in the Journal: (JOURNAL)
- what: The authors report the experience of treating Frontiers in Immunology The levels of HLHrelated cytokines IL-6, IL-10, and IFN-g decreased to 29.85, Frontiers in Immunology Discussion and literature review Here, the authors report cases of two patients with HLH secondary to AIDS who were successfully treated with ruxolitinib as the firstline therapy.
- future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.